Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Chinsuwan, Thanyavi, Hirabayashi, Koichi, Mishima, Shuji, Hasegawa, Aiko, Tanaka, Miyuki, Mochizuki, Hidemi, Shimoi, Akihito, Murakami, Takashi, Yagyu, Shigeki, Shimizu, Kimihiro, Nakazawa, Yozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582566/
https://www.ncbi.nlm.nih.gov/pubmed/37860015
http://dx.doi.org/10.1016/j.omto.2023.100735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582566/
https://www.ncbi.nlm.nih.gov/pubmed/37860015
http://dx.doi.org/10.1016/j.omto.2023.100735

Ejemplares similares